Impact of disease duration on coronary calcification in patients with acromegaly

Experimental and Clinical Endocrinology and Diabetes

Volumn 117, Issue 8, 2009, Pages 417-422

  Herrmann, B L ^a,b   Severing, M ^a   Schmermund, A ^c   Berg, C ^a   Budde, Th ^d   Erbel, R ^c   Mann, K ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b Division of Endocrinology and Diabetology   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d ALFRIED KRUPP KRANKENHAUS   (Germany)

Author keywords

Acromegaly; Coronary calcifi cation; Disease duration

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; GROWTH HORMONE; OCTREOTIDE; PEGVISOMANT; SOMATOMEDIN C;

ACROMEGALY; ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE DURATION; ELECTRON BEAM TOMOGRAPHY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MALE; PRIORITY JOURNAL;

ACROMEGALY; ADENOMA; ADULT; AGED; CALCINOSIS; CARDIOMYOPATHIES; CHEMILUMINESCENT MEASUREMENTS; CORONARY DISEASE; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; PROSPECTIVE STUDIES; RADIOSURGERY; RISK FACTORS; TIME FACTORS;

EID: 70350453976     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0029-1214386     Document Type: Article

References (33)

1. Melmed S. Acromegaly. N Engl J Med 1990 322 966-977
2. Colao A, Baldelli R, Marzullo P, et al. Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy. J Clin Endocrinol Metab 2000 85 193-199
3. Clayton RN. Cardiovascular function in acromegaly. Endocr Rev 2003 24 272-277
4. Colao A, Ferone D, Marzullo P, et al. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 2004 25 102-152
5. Herrmann BL, Bruch C, Saller B, et al. Occurrence of ventricular late potentials in patients with active acromegaly. Clin Endocrinol (Oxf) 2001 55 201-207
6. Lie JT. Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients. Am Heart J 1980 100 41-52
7. Otsuki M, Kasayama S, Yamamoto H, et al. Characterization of premature atherosclerosis of carotid arteries in acromegalic patients. Clin Endocrinol (Oxf) 2001 54 791-796
8. Erbel R, Schmermund A, Mohlenkamp S, et al. Electron-beam computed tomography for detection of early signs of coronary arteriosclerosis. Eur Heart J 2000 21 720-732
9. Erbel R, Mohlenkamp S, Kerkhoff G, et al. Non-invasive screening for coronary artery disease: calcium scoring. Heart 2007 93 1620-1629
10. Schmermund A, Erbel R. Unstable coronary plaque and its relation to coronary calcium. Circulation 2001 104 1682-1687
11. Wilson PW, DAgostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998 97 1837-1847
12. Giustina A, Barkan A, Casanueva FF, et al. Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 2000 85 526-529
13. Giustina A, Melmed S. Acromegaly consensus: the next steps. J Clin Endocrinol Metab 2003 88 1913-1914
14. Rakowski H, Appleton C, Chan KL, et al. Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: from the Investigators of Consensus on Diastolic Dysfunction by Echocardiography. J Am Soc Echocardiogr 1996 9 736-760
15. Schmermund A, Mohlenkamp S, Baumgart D, et al. Usefulness of topography of coronary calcium by electron-beam computed tomography in predicting the natural history of coronary atherosclerosis. Am J Cardiol 2000 86 127-132
16. Agatston AS, Janowitz WR, Hildner FJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990 15 827-832
17. Schmermund A, Mohlenkamp S, Berenbein S, et al. Population-based assessment of subclinical coronary atherosclerosis using electron-beam computed tomography. Atherosclerosis 2006 185 177-182
18. Austen WG, Edwards JE, Frye RL, et al. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975 51 5-40
19. Colao A, Cuocolo A, Marzullo P, et al. Impact of patient's age and disease duration on cardiac performance in acromegaly: a radionuclide angiography study. J Clin Endocrinol Metab 1999 84 1518-1523
20. Herrmann BL, Wessendorf TE, Ajaj W, et al. Effects of octreotide on sleep apnoea and tongue volume (magnetic resonance imaging) in patients with acromegaly. Eur J Endocrinol 2004 151 309-315
21. Herrmann BL, Baumann H, Janssen OE, et al. Impact of disease activity on thyroid diseases in patients with acromegaly: basal evaluation and follow-up. Exp Clin Endocrinol Diabetes 2004 112 225-230
22. Colao A, Marzullo P, Cuocolo A, et al. Reversal of acromegalic cardiomyopathy in young but not in middle-aged patients after 12 months of treatment with the depot long-acting somatostatin analogue octreotide. Clin Endocrinol (Oxf) 2003 58 169-176
23. Bruch C, Herrmann B, Schmermund A, et al. Impact of disease activity on left ventricular performance in patients with acromegaly. Am Heart J 2002 144 538-543
24. Herrmann BL, Bruch C, Saller B, et al. Acromegaly: evidence for a direct relation between disease activity and cardiac dysfunction in patients without ventricular hypertrophy. Clin Endocrinol (Oxf) 2002 56 595-602
25. Bogazzi F, Lombardi M, Strata E, et al. High prevalence of cardiac hypertophy without detectable signs of fibrosis in patients with untreated active acromegaly: an in vivo study using magnetic resonance imaging. Clin Endocrinol (Oxf) 2008 68 361-368
26. Kahaly G, Olshausen KV, Mohr-Kahaly S, et al. Arrhythmia profile in acromegaly. Eur Heart J 1992 13 51-56
27. Cannavo S, Almoto B, Cavalli G, et al. Acromegaly and coronary disease: an integrated evaluation of conventional coronary risk factors and coronary calcifications detected by computed tomography. J Clin Endocrinol Metab 2006 91 3766-3772
28. Bogazzi F, Battolla L, Spinelli C, et al. Risk factors for development of coronary heart disease in patients with acromegaly: a five-year prospective study. J Clin Endocrinol Metab 2007 92 4271-4277
29. Colao A, Spiezia S, Cerbone G, et al. Increased arterial intima-media thickness by B-M mode echodoppler ultrasonography in acromegaly. Clin Endocrinol (Oxf) 2001 54 515-524
30. Erbel R, Schmermund A. Clinical significance of coronary calcification. Arterioscler Thromb Vasc Biol 2004 24 e172 author reply e172
31. Schmermund A, Baumgart D, Gorge G, et al. Coronary artery calcium in acute coronary syndromes: a comparative study of electron-beam computed tomography, coronary angiography, and intracoronary ultrasound in survivors of acute myocardial infarction and unstable angina. Circulation 1997 96 1461-1469
32. Herrmann BL, Brandt-Mainz K, Saller B, et al. Myocardial perfusion abnormalities in patients with active acromegaly. Horm Metab Res 2003 35 183-188
33. Fazio S, Cittadini A, Cuocolo A, et al. Impaired cardiac performance is a distinct feature of uncomplicated acromegaly. J Clin Endocrinol Metab 1994 79 441-446